131 related articles for article (PubMed ID: 32631903)
21. Expression of B cell-associated transcription factors in B-cell precursor acute lymphoblastic leukemia cells: association with PU.1 expression, phenotype, and immunogenotype.
Nishii K; Kita K; Miwa H; Shikami M; Taniguchi M; Usui E; Katayama N; Shiku H
Int J Hematol; 2000 Jun; 71(4):372-8. PubMed ID: 10905058
[TBL] [Abstract][Full Text] [Related]
22. Nfkb1 activation by the E26 transformation-specific transcription factors PU.1 and Spi-B promotes Toll-like receptor-mediated splenic B cell proliferation.
Li SK; Abbas AK; Solomon LA; Groux GM; DeKoter RP
Mol Cell Biol; 2015 May; 35(9):1619-32. PubMed ID: 25733685
[TBL] [Abstract][Full Text] [Related]
23. Cell specific expression of human Bruton's agammaglobulinemia tyrosine kinase gene (Btk) is regulated by Sp1- and Spi-1/PU.1-family members.
Müller S; Sideras P; Smith CI; Xanthopoulos KG
Oncogene; 1996 Nov; 13(9):1955-64. PubMed ID: 8934542
[TBL] [Abstract][Full Text] [Related]
24. JAK3 mutants transform hematopoietic cells through JAK1 activation, causing T-cell acute lymphoblastic leukemia in a mouse model.
Degryse S; de Bock CE; Cox L; Demeyer S; Gielen O; Mentens N; Jacobs K; Geerdens E; Gianfelici V; Hulselmans G; Fiers M; Aerts S; Meijerink JP; Tousseyn T; Cools J
Blood; 2014 Nov; 124(20):3092-100. PubMed ID: 25193870
[TBL] [Abstract][Full Text] [Related]
25. PTPN2 negatively regulates oncogenic JAK1 in T-cell acute lymphoblastic leukemia.
Kleppe M; Soulier J; Asnafi V; Mentens N; Hornakova T; Knoops L; Constantinescu S; Sigaux F; Meijerink JP; Vandenberghe P; Tartaglia M; Foa R; Macintyre E; Haferlach T; Cools J
Blood; 2011 Jun; 117(26):7090-8. PubMed ID: 21551237
[TBL] [Abstract][Full Text] [Related]
26. SPI-C, a PU-box binding ETS protein expressed temporarily during B-cell development and in macrophages, contains an acidic transactivation domain located to the N-terminus.
Carlsson R; Persson C; Leanderson T
Mol Immunol; 2003 Jun; 39(16):1035-43. PubMed ID: 12749910
[TBL] [Abstract][Full Text] [Related]
27. PU.1 Regulates Ig Light Chain Transcription and Rearrangement in Pre-B Cells during B Cell Development.
Batista CR; Li SK; Xu LS; Solomon LA; DeKoter RP
J Immunol; 2017 Feb; 198(4):1565-1574. PubMed ID: 28062693
[TBL] [Abstract][Full Text] [Related]
28. A Recurrent Activating Missense Mutation in Waldenström Macroglobulinemia Affects the DNA Binding of the ETS Transcription Factor SPI1 and Enhances Proliferation.
Roos-Weil D; Decaudin C; Armand M; Della-Valle V; Diop MK; Ghamlouch H; Ropars V; Hérate C; Lara D; Durot E; Haddad R; Mylonas E; Damm F; Pflumio F; Stoilova B; Metzner M; Elemento O; Dessen P; Camara-Clayette V; Cosset FL; Verhoeyen E; Leblond V; Ribrag V; Cornillet-Lefebvre P; Rameau P; Azar N; Charlotte F; Morel P; Charbonnier JB; Vyas P; Mercher T; Aoufouchi S; Droin N; Guillouf C; Nguyen-Khac F; Bernard OA
Cancer Discov; 2019 Jun; 9(6):796-811. PubMed ID: 31018969
[TBL] [Abstract][Full Text] [Related]
29. Stat5-deficient hematopoiesis is permissive for Myc-induced B-cell leukemogenesis.
Wang Z; Medrzycki M; Bunting ST; Bunting KD
Oncotarget; 2015 Oct; 6(30):28961-72. PubMed ID: 26338970
[TBL] [Abstract][Full Text] [Related]
30. c-Myb and members of the c-Ets family of transcription factors act as molecular switches to mediate opposite steroid regulation of the human glucocorticoid receptor 1A promoter.
Geng CD; Vedeckis WV
J Biol Chem; 2005 Dec; 280(52):43264-71. PubMed ID: 16263717
[TBL] [Abstract][Full Text] [Related]
31. Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia.
Zenatti PP; Ribeiro D; Li W; Zuurbier L; Silva MC; Paganin M; Tritapoe J; Hixon JA; Silveira AB; Cardoso BA; Sarmento LM; Correia N; Toribio ML; Kobarg J; Horstmann M; Pieters R; Brandalise SR; Ferrando AA; Meijerink JP; Durum SK; Yunes JA; Barata JT
Nat Genet; 2011 Sep; 43(10):932-9. PubMed ID: 21892159
[TBL] [Abstract][Full Text] [Related]
32. Tumor-specific HSP90 inhibition as a therapeutic approach in JAK-mutant acute lymphoblastic leukemias.
Kucine N; Marubayashi S; Bhagwat N; Papalexi E; Koppikar P; Sanchez Martin M; Dong L; Tallman MS; Paietta E; Wang K; He J; Lipson D; Stephens P; Miller V; Rowe JM; Teruya-Feldstein J; Mullighan CG; Ferrando AA; Krivtsov A; Armstrong S; Leung L; Ochiana SO; Chiosis G; Levine RL; Kleppe M
Blood; 2015 Nov; 126(22):2479-83. PubMed ID: 26443624
[TBL] [Abstract][Full Text] [Related]
33. Lack of constitutive activation of Janus kinases and signal transduction and activation of transcription factors in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Kanwar VS; Witthuhn B; Campana D; Ihle JN
Blood; 1996 Jun; 87(11):4911-2. PubMed ID: 8639867
[No Abstract] [Full Text] [Related]
34. PU.1: a crucial and versatile player in hematopoiesis and leukemia.
Kastner P; Chan S
Int J Biochem Cell Biol; 2008; 40(1):22-7. PubMed ID: 17374502
[TBL] [Abstract][Full Text] [Related]
35. PU.1 exhibits partial functional redundancy with Spi-B, but not with Ets-1 or Elf-1.
Garrett-Sinha LA; Dahl R; Rao S; Barton KP; Simon MC
Blood; 2001 May; 97(9):2908-12. PubMed ID: 11313289
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
[TBL] [Abstract][Full Text] [Related]
37. Identification of mutant alleles of JAK3 in pediatric patients with acute lymphoblastic leukemia.
Yin C; Sandoval C; Baeg GH
Leuk Lymphoma; 2015 May; 56(5):1502-6. PubMed ID: 25146434
[TBL] [Abstract][Full Text] [Related]
38. IKZF3/Aiolos H195Y mutation identified in a mouse model of B cell leukemia results in altered DNA binding and altered STAT5-dependent gene expression.
Rodrigues de Oliveira B; Iansavitchous J; Rysan H; Wang WC; Sams MP; Knight D; Xu LS; Jeong J; Qu TP; Zorzi AP; DeKoter RP
Gene; 2024 Mar; 900():148131. PubMed ID: 38216003
[TBL] [Abstract][Full Text] [Related]
39. A transgenic mouse model for TEL-JAK2-induced B-cell lymphoma/leukemia.
dos Santos NR; Ghysdael J
Leukemia; 2006 Jan; 20(1):182-5. PubMed ID: 16281066
[No Abstract] [Full Text] [Related]
40. The +37 kb Cebpa Enhancer Is Critical for Cebpa Myeloid Gene Expression and Contains Functional Sites that Bind SCL, GATA2, C/EBPα, PU.1, and Additional Ets Factors.
Cooper S; Guo H; Friedman AD
PLoS One; 2015; 10(5):e0126385. PubMed ID: 25938608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
